#DrugDiscovery

Geekoogeekoo
2025-06-25

Could a fungus from ancient tombs help cure cancer? Meet the Penn team turning deadly spores into the next breakthrough drug.

geekoo.news/from-deadly-fungus

MoveTheNeedle.news OfficialMoveTheNeedle@masto.nu
2025-06-24

🚀 Mavatar, the Swedish #HealthTech innovator, is launching in the U.S. with a game-changing AI platform for #PrecisionMedicine. Mavatar Discovery helps simulate disease progression, discover biomarkers, and repurpose drugs using transcriptomic data and machine learning.
Read our exclusive interview with Mavatar CEO Johan Juhlin.
👉 movetheneedle.news/start-ups/u
#AI #DigitalTwins #DrugDiscovery #RareDiseases #Biotech #OpenScience #Mavatar #HealthcareInnovation

2025-06-24

We have an exciting program of talks for you for the @LED3hub Lectures 2025/2026!

If you are interested, already mark your calendars and come by to learn about various aspects of early drug discovery. universiteitleiden.nl/en/scien

#DrugDiscovery #ChemSky #Chemistry #ChemBio

We have an exciting program of talks for you for the @led3hub.bsky.social Lectures 2025/2026! If you are interested, already mark your calendars and come by to learn about various aspects of early drug discovery. www.universiteitleiden.nl/en/science/l... #DrugDiscovery #ChemSky #Chemistry #ChemBio

RE: https://bsky.app/profile/did:plc:jnlt3o3km3ebst2vcigkwdch/post/3lse3k54hnc27

2025-06-23

Are you an academic researcher running #MolecularDocking?

Leverage #BOINC Central to access free, large-scale distributed computing for your #AutoDock #Vina jobs.
Our guide walks you through setup to submission:
github.com/BOINC/boinc-autodoc

#Autodock:
youtu.be/NJ8sxnipMUs

#Vina:
youtu.be/ypBh-Sw_jTg

#Vinardo:
youtu.be/dGiZbEje-Ok

#Vina and #Raccoon2:
youtu.be/g7jago5-TvU

#DrugDiscovery #VirtualScreening #HPC

2025-06-19

The final #FlashTalk session gave another exciting overview of different early #DrugDiscovery topics including #CovalentInhibitors for glycosidases (Rob Lammers), host-directed therapies for bacterial infections (Bart van Lieshout) and covalently drugging transcription factors (Shaima Abdalla).

2025-06-19

The second #FlashTalk session at #LED3Symposium was another firework of diverse early #DrugDiscovery topics including β-lactamase evolution (Cristina López Gallego), EC50 determinations (Chenyu Wang), transcription factor inhibitors (Brecht Ellenbroek) and natural products discovery (Pavlo Hrab).

2025-06-17

Call for papers

Disease Models & Mechanisms (DMM) invites you to submit your latest research to their upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery.

Find out more: journals.biologists.com/dmm/pa

#InVitro #DrugDiscovery #Research #CallForPapers #Disease #Humans #HumanDisease #Science #Communication #Experiment

Special Issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery
Edited by Vivian Li, Austin Smith and Joseph Wu
Submission deadline: 6 October 2025
Brad Watmuffbradgy
2025-06-17

We used NGN2-reprogrammed iPSC neurons with glutamatergic hyperactivity and tested phenytoin, perampanel, and carbamazepine.

Read the full paper here 👇
📄 Communications Biology
🔗 dx.doi.org/10.1038/s42003-025-

Richard Dallawayd6y@mastodon.green
2025-06-13

On Tuesday the UK government announced OpenBind. It looks really exciting for generating a ton of molecule-protein datasets. I think it's going to be important, if it goes well.

r.dallaway.com/posts/openbind-

#ai #drugDiscovery

2025-06-13

Despite a century of use in #DrugDiscovery, specialized metabolism continues to amaze. Justin Nodwell explores a @PLOSBiology study that uses a novel computational approach to uncover unsuspected functions of a compound produced by #Streptomyces. Paper: plos.io/43UVUPB Primer: plos.io/4n25bOF

Proposed biosynthetic pathway for assembly of desferrioxamines E and B. Main biosynthetic enzymes presented in bold face. DesG and DesH balance intracellular N-hydroxy-N-succinylcadaverine (HSC) and N-hydroxy-N-acetylcadaverine (HAC) concentrations by converting HSC to HAC. In the absence of DesG and/or DesH, the cells likely fail to produce sufficient levels of HAC, thereby strongly attenuating the production of DFOB. Although DesC has been shown to be able to catalyze the acetylation of N-hydroxycadaverine in vitro, the enzyme can only modestly compensate for the loss of DesH in vivo, underlining the important role played by DesG and DesH in DFOB production.
2025-06-13

alojapan.com/1296892/japans-ol Japan’s Oldest Pharma Firm to Be Sold to Bain Capital #acquisition #BainCapital #DrugDiscovery #Economy&Tech #Japan #JapanNews #JapanTopics #JapaneseCompanies #MitsubishiChemical #MitsubishiTanabePharma #news #PharmaCompany #Pharmaceutical #PharmaceuticalCompany #PharmaceuticalIndustry #PrivateEquity Mitsubishi Tanabe Pharma, Japan’s oldest pharmaceutical company with a 350-year history, is approaching a major turning point. Its par…

6DYEU4JU6JPLJHZVEWVFOTWVL4-min
Fali Fuentesfalitroke
2025-06-07

🌿 Natural products hold the key to life-saving medicines, but their complexity has always been a barrier. Exciting news: enzymatic and genetic breakthroughs are now making their synthesis easier! What could this mean for future drug development? 🧬💡 phys.org/news/2025-05-enzymati

Trending Stocks 📈stonkz
2025-06-03

AI: Cure All Diseases - Eric Schmidt on AI

2025-05-30

🧬 New review out in Drug Discovery Today:

🔗 doi.org/10.1016/j.drudis.2025.

We take a critical look at how AI — especially AlphaFold(-Multimer/3) — has changed protein complex prediction.

End-to-end models work well for rigid complexes. Flexibility, disorder, and transient interfaces remain unsolved.

AI is shiny. Biology is complicated. We map what’s working, what isn’t, and what’s next.

Newsrampnewsramp
2025-05-24

CD BioSciences launches customizable aging mouse models, revolutionizing preclinical drug research with advanced gene-editing and comprehensive research support. Accelerating discoveries in age-related disease treatments.

Newsramp Image

Excited to be at VU Amsterdam to listen to the Nauta Lecture of György Keserű on "Covalent fragment approaches in drug discovery". He gave a great overview of his group`s many groundbreaking contributions to tool development for #DrugDiscovery and his newest work on photoactivatable fragments.(1/7)

He started by giving a very clear overview of the concept of #CovalentInhibitors and the important advantages that they can have in #DrugDiscovery. He especially highlighted, how powerful covalent fragments can be in this context. (2/7) www.sciencedirect.com/science/arti...

Covalent fragment approaches t...

2025-05-23

He started by giving a very clear overview of the concept of #CovalentInhibitors and the important advantages that they can have in #DrugDiscovery. He especially highlighted, how powerful covalent fragments can be in this context. (2/7) sciencedirect.com/science/arti

Client Info

Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst